Table 5 Cost-effectiveness performance (Value for Money score) for the interventions
From: A decision support tool with health economic modelling for better management of DVT patients
Scenario | NOAC treatment in CSs | Standard treatment in CSs | NOAC treatment in Hospital | Standard treatment in hospital |
|---|---|---|---|---|
Baseline | N/A | N/A | N/A | N/A |
Scenario 1 | 336.4 | 66.1 | 111.2 | 25.0 |
Scenario 2 | 251.4 | 64.7 | 115.1 | 25.5 |
Scenario 3 | 194.1 | 68.9 | 121.1 | 25.1 |
Scenario 4 | 174.2 | 65.7 | 119.2 | 25.2 |
Scenario 5 | 295.7 | 64.6 | 103.9 | 25.0 |
Scenario 6 | 237.1 | 64.2 | 112.7 | 25.9 |
Scenario 7 | 186.0 | 67.1 | 121.3 | 25.1 |
Scenario 8 | 176.7 | 68.3 | 121.3 | 25.5 |
Scenario 9 | 258.1 | 66.2 | 89.0 | 25.0 |
Scenario 10 | 219.2 | 68.0 | 106.2 | 25.4 |
Scenario 11 | 189.8 | 68.5 | 119.6 | 24.7 |
Scenario 12 | 185.4 | 69.4 | 120.1 | 25.3 |
Scenario 13 | 236.5 | 64.3 | 86.1 | 25.2 |
Scenario 14 | 207.4 | 66.9 | 105.5 | 25.7 |
Scenario 15 | 184.8 | 67.2 | 121.1 | 25.0 |
Scenario 16 | 182.5 | 68.0 | 121.1 | 26.3 |